Patents Assigned to UNIVERSIDAD PABLO DE OLAVIDE
  • Publication number: 20190194749
    Abstract: The invention relates to a method for the diagnosis of liver fibrosis, comprising detecting the level of expression of the gene GATA-4, or the quantity of the protein GATA-4, in the isolated biological sample of liver tissue. The invention also relates to a diagnosis kit.
    Type: Application
    Filed: April 30, 2014
    Publication date: June 27, 2019
    Applicants: UNIVERSIDAD PABLO DE OLAVIDE, UNIVERSIDAD DE SEVILLA, SERVICIO ANDALUZ DE SALUD, FUNDACIÓN PÚBLICA ANDALUZA PARA LA GESTIÓN DE LA INVESTIGACIÓN EN SALUD DE SEVILLA
    Inventors: Ana Isabel Rojas Gonzalez, David Cano Gonzalez, Irene Delgado Sainz, Bernat Soria Escoms, Francisco Martin Bermudez, Manuel Romero Gomez
  • Publication number: 20160361244
    Abstract: The present invention relates to the use of the inhibitor of the activity of the steroid sulfatase enzyme STX64 for the treatment of ageing and, therefore, to increase the longevity of individuals or improve their quality of life. It also relates to a cosmetic composition that comprises said inhibitor for that purpose.
    Type: Application
    Filed: March 26, 2014
    Publication date: December 15, 2016
    Applicant: Universidad Pablo de Olavide
    Inventors: Manuel Jesus Munoz Ruiz, Maria Mercedes Perez Jimenez
  • Publication number: 20140234983
    Abstract: The present invention relates to a method of obtaining metal nanoparticles functionalized with fluorescent organic molecules by means of the treatment of one or more metal salts with a reducing agent in the presence of a fluorescent organic molecule. The invention also relates to the metal nanoparticles obtainable by said method and to their use for detecting molecules and analytes.
    Type: Application
    Filed: March 23, 2012
    Publication date: August 21, 2014
    Applicants: UNIVERSIDAD PABLO DE OLAVIDE, CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS C.S.I.C.
    Inventors: Ana Paula Zaderenko Partida, Carlos Caro Salazar, José Mejías Romero, Maria Jesús Sayagués De Vega
  • Patent number: 8481500
    Abstract: The invention relates to the use of morin and mangiferin, the pharmaceutically acceptable salts, prodrugs and/or solvates thereof in the production of a pharmaceutical composition for the prevention and/or treatment of a neurodegenerative disease and symptoms associated with ageing, as well as to food compositions comprising said compounds.
    Type: Grant
    Filed: December 29, 2006
    Date of Patent: July 9, 2013
    Assignees: Universidad del Pais Vasco, Universidad Pablo de Olavide
    Inventors: Carlos Matute Almau, Maria Victoria Sanchez Gomez, Rosario Campos Esparza, Elena Alberdi Alfonso, Miroslav Gottlieb, Gaskon Ibarretxe Bilbao, Jose Maria Delgado Garcia, Agnes Gruart I Masso, Rocio Leal Campanario
  • Publication number: 20090131339
    Abstract: The invention relates to the use of morin and mangiferin, the pharmaceutically acceptable salts, prodrugs and/or solvates thereof in the production of a pharmaceutical composition for the prevention and/or treatment of a neurodegenerative disease and symptoms associated with ageing, as well as to food compositions comprising said compounds.
    Type: Application
    Filed: December 29, 2006
    Publication date: May 21, 2009
    Applicants: UNIVERSIDAD DEL PAIS VASCO, UNIVERSIDAD PABLO DE OLAVIDE
    Inventors: Carlos Matute Almau, Maria Victoria Sanchez Gomez, Rosario Campos Esparza, Elena Alberdi Alfonso, Miroslav Gottlieb, Gaskon Ibarretxe Bilbao, Jose Maria Delgado Garcia, Agnes Gruart I Masso, Rocio Leal Campanario